Gain Therapeutics (GANX) Prepaid Assets (2020 - 2026)
Gain Therapeutics (GANX) posted quarterly Prepaid Assets of $358059.0 for Q1 2026, down 57.45% year-over-year from $841446.0 in Q1 2025, and up 361.46% quarter-over-quarter from $77593.0 in Q4 2025.
Gain Therapeutics (GANX) Prepaid Assets (2020 - 2026) Analysis & Trends
Gain Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $358059.0 for Q1 2026.
- In Q1 2026, Prepaid Assets fell 57.45% year-over-year to $358059.0; the TTM figure through Mar 2026 stood at $358059.0 (down 57.45% YoY), while the FY2025 annual figure was $77593.0, down 63.09% from the prior year.
- Prepaid Assets for Q1 2026 stood at $358059.0, up from $77593.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.9 million in Q1 2022, with the low at $77593.0 in Q4 2025.
- The 5-year median for Prepaid Assets is $605502.0 (2023), against an average of $691861.2.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets surged 274.4% in 2022, then sank 74.29% in 2025.
- Gain Therapeutics' Prepaid Assets stood at $552882.0 in 2022, then jumped by 34.14% to $741638.0 in 2023, then sank by 71.66% to $210201.0 in 2024, then tumbled by 63.09% to $77593.0 in 2025, then surged by 361.46% to $358059.0 in 2026.
- Business Quant data shows GANX's Prepaid Assets at $358059.0 in Q1 2026, $77593.0 in Q4 2025, and $421924.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Gain Therapeutics | 85.97 Mn | 85.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 Mn |
| Mar 31, 2026 | 358,059.00 |
| Dec 31, 2025 | 77,593.00 |
| Sep 30, 2025 | 421,924.00 |
| Jun 30, 2025 | 261,365.00 |
| Mar 31, 2025 | 841,446.00 |
| Dec 31, 2024 | 210,201.00 |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 952,889.00 |
| Dec 31, 2023 | 741,638.00 |
| Sep 30, 2023 | 906,834.00 |
| Jun 30, 2023 | 448,001.00 |
| Mar 31, 2023 | 605,502.00 |
| Dec 31, 2022 | 552,882.00 |
| Sep 30, 2022 | 452,291.00 |
| Jun 30, 2022 | 664,025.00 |
| Mar 31, 2022 | 1.93 Mn |
| Dec 31, 2021 | 147,671.00 |
| Sep 30, 2021 | 291,666.00 |